Browsing Wolfson Institute of Preventive Medicine by Author "Gaba, F"
Now showing items 1-20 of 24
-
505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study
Gaba, F; Blyuss, O; Legood, R; Izatt, L; Tripathi, V; Ragupathy, K; Crawfordd, R; Evans, DG; Menon, U; Manchanda, R (BMJ, 2020-12-04)Abstract 505 from ESGO SoA 2020 Conference Abstracts. [Abstract only] -
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study
Gaba, F; Blyuss, O; Chandrasekaran, D; Osman, M; Goyal, S; Gan, C; Izatt, L; Tripathi, V; Esteban, I; McNicol, L (2020-08-16) -
Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
Gaba, F; Blyuss, O; Tan, A; Munblit, D; Oxley, S; Khan, K; Legood, R; Manchanda, R (2023) -
Economic Evaluation of Population-BasedBRCA1/BRCA2Mutation Testing across Multiple Countries and Health Systems
Manchanda, R; Sun, L; Patel, S; Evans, O; Wilschut, J; De Freitas Lopes, AC; Gaba, F; Brentnall, A; Duffy, S; Cui, B (MDPI, 2020-07-17) -
IMPACT OF POPULATION GENETIC TESTING AND OVARIAN CANCER RISK STRATIFICATION ON THE EMOTIONAL WELL-BEING AND HEALTH OF UNSELECTED WOMEN IN A GENERAL POPULATION
Gaba, F; Liu, X; Chandrasekaran, D; Kalsi, J; Antoniou, A; Side, L; Menon, U; Jacobs, I; Marks, D; Manchanda, R (BMJ Publishing Group Ltd., 2019-11-01) -
Impact of SARS-CoV-2 on Training and Mental Well-being of Surgical Gynaecological Oncology Trainees
Gaba, F; Blyuss, O; Manchanda, RThe SARS-CoV-2 global pandemic has caused a crisis disrupting health systems worldwide. While efforts are being made to determine the extent of the disruption, the impact on gynecological oncology trainees/training has not ... -
IMPACT OF SARS-COV-2 ON TRAINING AND MENTAL WELLBEING OF SURGICAL GYNAECOLOGICAL ONCOLOGY TRAINEES
Gaba, F; Blyuss, O; Rodriguez, I; Dilley, J; Wan, YL; Saiz, A; Razumova, Z; Zalewski, K; Nikolova, T; Selcuk, I (2021) -
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study.
Chandrasekaran, D; Sobocan, M; Blyuss, O; Miller, RE; Evans, O; Crusz, SM; Mills-Baldock, T; Sun, L; Hammond, RFL; Gaba, F (MDPI, 2021-08-27)We present findings of a cancer multidisciplinary-team (MDT) coordinated mainstreaming pathway of unselected 5-panel germline BRCA1/BRCA2/RAD51C/RAD51D/BRIP1 and parallel somatic BRCA1/BRCA2 testing in all women with ... -
International Variations in Surgical Morbidity and Mortality Post Gynaecological Oncology Surgery: A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study (GO SOAR1).
Gaba, F; Ash, K; Blyuss, O; Bizzarri, N; Kamfwa, P; Saiz, A; Cibula, D; Go Soar Collaborators (2023-10-16)Gynaecological malignancies affect women in low and middle income countries (LMICs) at disproportionately higher rates compared with high income countries (HICs) with little known about variations in access, quality, and ... -
Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)
Gaba, F; Ash, K; Blyuss, O; Bizzarri, N; Kamfwa, P; Ramirez, PT; Kotsopoulos, IC; Chandrasekaran, D; Gomes, N; Butler, J (2022) -
Population Screening for Inherited Predisposition to Breast and Ovarian Cancer
Manchanda, R; Lieberman, S; Gaba, F; Lahad, A; Levy-Lahad, E (Annual Reviews, 2020-08-31)The discovery of genes underlying inherited predisposition to breast and ovarian cancer has revolutionized the ability to identify women at high risk for these diseases before they become affected. Women who are carriers ... -
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention
Gaba, F; Blyuss, O; Liu, X; Goyal, S; Lahoti, N; Chandrasekaran, D; Kurzer, M; Kalsi, J; Sanderson, S; Lanceley, A (MDPI AG, 2020-05-15)Unselected population-based personalised ovarian cancer (OC) risk assessment combining genetic/epidemiology/hormonal data has not previously been undertaken. We aimed to perform a feasibility study of OC risk stratification ... -
Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention
Gaba, F; Blyuss, O; Sanderson, S; Antoniou, A; Kalsi, J; Wallace, A; Menon, U; Legood, R; Jacobs, I; Manchanda, R (2020-12-04)Abstract 401 from ESGO SoA 2020 Conference Abstracts -
Population-based genetic testing for Women's cancer prevention
Evans, O; Gaba, F; Manchanda, R (Elsevier BV, 2020-03-02) -
POST-OPERATIVE MORBIDITY & MORTALITY FOLLOWING GYNAECOLOGICAL ONCOLOGY SURGERY: PROTOCOL FOR A GLOBAL PROSPECTIVE COHORT STUDY (GO SOAR1)
Gaba, F; Bizzarri, N; Kamfwa, P; Saiz, A; Blyuss, O; Paranjothy, S; Ramirez, P; Cibula, D (2021) -
PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS)
Manchanda, R; Gaba, F; Bottla, K; Mousa, K; Burnell, M; Kalsi, J; Gentry-Maharaj, A; Antoniou, A; Blyuss, O; Zaikin, A (2017-11) -
PREVENTING OVARIAN CANCER THROUGH EARLY EXCISION OF TUBES AND LATE OVARIAN REMOVAL (PROTECTOR) STUDY
Gaba, F; Chandrasekaran, D; Menon, U; Evans, G; Singh, N; McCluggage, G; Wilkinson, N; Ganesan, R; Rowlands, G; Bryson, G (2019-11) -
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
Gaba, F; Robbani, S; Singh, N; McCluggage, WG; Wilkinson, N; Ganesan, R; Bryson, G; Rowlands, G; Tyson, C; Arora, R (2020-09-08)BACKGROUND: Risk-reducing salpingo-oophorectomy is the 'gold standard' for preventing tubo-ovarian cancer in women at increased risk. However, when performed in pre-menopausal women, it results in premature menopause and ... -
Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis
Gaba, F; Blyuss, O; Chandrasekaran, D; Bizzarri, N; Refky, B; Barton, D; Ind, T; Nobbenhuis, M; Butler, J; Heath, O<jats:p>For women achieving clinical remission after the completion of initial treatment for epithelial ovarian cancer, 80% with advanced-stage disease will develop recurrence. However, the standard treatment of women with ... -
RANDOMISED TRIAL OF UNSELECTED BRCA TESTING IN ASHKENAZI JEWS: LONG TERM OUTCOMES AND FACTORS AFFECTING UPTAKE OF TESTING
Manchanda, R; Burnell, M; Gaba, F; Desai, R; Wardle, J; Gessler, S; Side, L; Sanderson, S; Loggenberg, K; Brady, A (BMJ, 2019-11)Abstract from ESGO Annual Meeting Abstracts